Working… Menu
Trial record 3 of 6 for:    "Neuromyelitis Optica" | "Antirheumatic Agents"

Comparison of Clinical Effects of Azathioprine and Rituximab NMO-SD Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03002038
Recruitment Status : Completed
First Posted : December 23, 2016
Last Update Posted : January 2, 2017
Information provided by (Responsible Party):
Vahid Shaygannejad, Isfahan University of Medical Sciences

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Completed
Actual Primary Completion Date : November 2016
Actual Study Completion Date : December 2016
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 October 2, 2018
February 14, 2019
2 April 23, 2019
July 10, 2019
Publications automatically indexed to this study by Identifier (NCT Number):